InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: Biobillionair post# 9037

Monday, 06/24/2013 9:55:57 AM

Monday, June 24, 2013 9:55:57 AM

Post# of 426232
A smart R&D team could build an armada of block busters NCE/combo Vascepa's in a short time period. Many of these drugs could achieve orphan status exclusivity.

Example:
Orphan status for Sepsis Treatment:
IV Tylenol + EPA (has been given IV for CV studies)

http://www.ccmtutorials.com/infection/sepsis/page4.htm


Amarin should expand R&D and start the ball rolling.

Williams
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News